×

Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens

  • US 20030044409A1
  • Filed: 05/01/2001
  • Published: 03/06/2003
  • Est. Priority Date: 05/01/2001
  • Status: Abandoned Application
First Claim
Patent Images

1. A purified antibody for modulating a biological activity of a malignant cell that expresses a frizzled receptor, wherein said antibody specifically binds to at least one epitope in an extracellular domain of the frizzle receptor expressed on the malignant cell.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×